Updated Guidance: Second Dose of COVID-19 Vaccine for Older Adults and Immunocompromised Individuals

The CDC now recommends that individuals aged 65 and older, as well as those who are moderately or severely immunocompromised, receive a second dose of the 2024-2025 COVID-19 vaccine six months after their initial dose. This guideline, endorsed by CDC Director Mandy Cohen, highlights the increased risk of severe disease for these groups and emphasizes the importance of maintaining vaccination to combat COVID-19 and its variants.

 

Additionally, individuals with weakened immune systems may receive additional doses based on shared decision-making with healthcare providers. Ongoing vaccination is crucial not only for reducing severe outcomes but also for minimizing the risk of Long COVID. Read more from the CDC here.